Utrecht Coronary Biobank (UCORBIO) (UCORBIO)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02304744|
Recruitment Status : Unknown
Verified March 2015 by Crystel Gijsberts, UMC Utrecht.
Recruitment status was: Active, not recruiting
First Posted : December 2, 2014
Last Update Posted : March 6, 2015
UCORBIO enrolls patients who undergo coronary angiography (for any indication). The investigators draw blood at the moment of insertion of the procedural arterial catheter.
At the moment of inclusion indication, procedural details, risk factor status, medication use and quality of life (RAND-36 and EuroQoL) is assessed. Patients are then followed-up for the occurrence of major adverse cardiovascular events for 5 years. During the follow-up period patients receive a questionnaire every year to check for hospital admissions. The questionnaires at two and five years of follow-up are enriched with quality of life questionnaires (RAND-36 and EuroQoL).
|Condition or disease||Intervention/treatment|
|Coronary Artery Disease||Other: Observational study, no intervention.|
|Study Type :||Observational|
|Estimated Enrollment :||3000 participants|
|Official Title:||Utrecht Coronary Biobank (UCORBIO)|
|Study Start Date :||October 2011|
|Actual Primary Completion Date :||December 2014|
|Estimated Study Completion Date :||December 2019|
- Other: Observational study, no intervention.
Observational study, no intervention.
- major adverse cardiovascular events [MACE] (Stroke, myocardial infarction, coronary revascularization, death) [ Time Frame: 5 years ]Stroke, myocardial infarction, coronary revascularization, death.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02304744
|Utrecht, Netherlands, 3508GA|